These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
590 related articles for article (PubMed ID: 19685467)
21. India's health biotech sector at a crossroads. Frew SE; Rezaie R; Sammut SM; Ray M; Daar AS; Singer PA Nat Biotechnol; 2007 Apr; 25(4):403-17. PubMed ID: 17420744 [No Abstract] [Full Text] [Related]
22. How should public policy respond to the challenges of modern biotechnology? Cantley M Curr Opin Biotechnol; 2004 Jun; 15(3):258-63. PubMed ID: 15193337 [TBL] [Abstract][Full Text] [Related]
23. Case study: India's billion dollar biotech. Chakma J; Masum H; Perampaladas K; Heys J; Singer PA Nat Biotechnol; 2010 Aug; 28(8):783. PubMed ID: 20697399 [No Abstract] [Full Text] [Related]
24. Biotechnology consortia versus multifirm alliances: paradigm shift at work? Persidis A; Persidis A Nat Biotechnol; 1996 Dec; 14(13):1657-60. PubMed ID: 9634847 [No Abstract] [Full Text] [Related]
25. A work in progress. Polvino B Nat Biotechnol; 2012 May; 30(5):388-9. PubMed ID: 22565957 [No Abstract] [Full Text] [Related]
26. An embargoed Cuban science. Smith C Genet Anal; 1999 Nov; 15(3-5):71-2. PubMed ID: 10596742 [No Abstract] [Full Text] [Related]
27. Left in the dust of the campaign trail. Nat Biotechnol; 2000 Nov; 18(11):1119. PubMed ID: 11062387 [No Abstract] [Full Text] [Related]
28. Portugal opens its borders to biotechnology. Louët S Nat Biotechnol; 2000 Mar; 18(3):276-7. PubMed ID: 10700139 [No Abstract] [Full Text] [Related]
29. Biotech's wellspring: a survey of the health of the private sector. Huggett B Nat Biotechnol; 2012 May; 30(5):395-400. PubMed ID: 22565961 [No Abstract] [Full Text] [Related]
30. India shuts door on embryonic export market. Jayaraman KS Nature; 2002 Sep; 419(6904):238. PubMed ID: 12239528 [No Abstract] [Full Text] [Related]
31. Italy, caught between old woes and new hopes. Meldolesi A Nat Biotechnol; 2001 Jun; 19(6):516-7. PubMed ID: 11385443 [No Abstract] [Full Text] [Related]
32. Global health public-private partnerships: IAVI, partnerships and capacity building. Hanlin R; Chataway J; Smith J Afr J Med Med Sci; 2007; 36 Suppl():69-75. PubMed ID: 17703568 [TBL] [Abstract][Full Text] [Related]
34. Packaging challenges: the solution is just beyond the border. Merritt J Med Device Technol; 2003 Mar; 14(2):12-5. PubMed ID: 12698691 [TBL] [Abstract][Full Text] [Related]
35. Russia becomes attractive as a source of IP for biotechs. Katsnelson A Nat Biotechnol; 2004 Sep; 22(9):1060. PubMed ID: 15340454 [No Abstract] [Full Text] [Related]
36. Introduction: promoting global health through biotechnology. Thorsteinsdóttir H; Quach U; Martin DK; Daar AS; Singer PA Nat Biotechnol; 2004 Dec; 22 Suppl():DC3-7. PubMed ID: 15583681 [No Abstract] [Full Text] [Related]
37. Forming an international biotechnology spinout: is it worth it? Christoffersen RE Nat Biotechnol; 1999 Feb; 17 Suppl():BE20-1. PubMed ID: 10052319 [No Abstract] [Full Text] [Related]
38. Biotech marks time in Q3. Lawrence S Nat Biotechnol; 2005 Nov; 23(11):1332. PubMed ID: 16273049 [No Abstract] [Full Text] [Related]
39. Biotechnology and bioeconomy in China. Li Q; Zhao Q; Hu Y; Wang H Biotechnol J; 2006 Nov; 1(11):1205-14. PubMed ID: 17109491 [TBL] [Abstract][Full Text] [Related]
40. Profiles of four top biotech companies in India. Suresh N; Rao ChS Biotechnol J; 2009 Mar; 4(3):295-300. PubMed ID: 19296435 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]